Fuller & Thaler Asset Management, Inc. Tandem Diabetes Care Inc Transaction History

Fuller & Thaler Asset Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$77.0 - $100.19 $6.71 Million - $8.74 Million	-87,192 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$81.28 - $104.34 $114,767 - $147,328	1,412 Added 1.65%	87,192 $7.7 Million
Q4 2020 Feb 11, 2021	BUY	$86.4 - $121.75 $156,988 - $221,219	1,817 Added 2.16%	85,780 $8.21 Million
Q3 2020 Nov 09, 2020	SELL	$95.43 - $116.09 $4.21 Million - $5.13 Million	-44,149 Reduced 34.46%	83,963 $9.53 Million
Q2 2020 Aug 13, 2020	BUY	$60.05 - $98.92 $176,246 - $290,330	2,935 Added 2.34%	128,112 $12.7 Million
Q1 2020 May 06, 2020	SELL	$47.37 - $90.04 $59,023 - $112,189	-1,246 Reduced 0.99%	125,177 $8.06 Million
Q4 2019 Feb 14, 2020	SELL	$53.13 - $71.19 $186,008 - $249,236	-3,501 Reduced 2.69%	126,423 $7.54 Million
Q3 2019 Nov 13, 2019	BUY	$57.11 - $73.3 $8,052 - $10,335	141 Added 0.11%	129,924 $7.66 Million
Q2 2019 Aug 13, 2019	BUY	$54.41 - $71.7 $28,782 - $37,929	529 Added 0.41%	129,783 $8.37 Million
Q1 2019 May 14, 2019	BUY	$32.25 - $73.56 $4.17 Million - $9.51 Million	129,254 New	129,254 $8.21 Million

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.